Today in the web issue of Cancer Cell The study was published.

Abate-Shen. That is just a first rung on the ladder toward a deeper understanding of the genetics of cancer, said Michael M. Shen, PhD, professor of medical sciences, of genetics and development, and of urological sciences at CUMC, who contributed to the analysis also. The tools and methods developed in this research may have wide utility in studying prostate cancer; cross-species computational analyses also could possibly be used to identify the sources of other cancers, as well as that of other complicated illnesses. The paper is titled Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy.Accurate, non-invasive and inexpensive test can detect Alzheimer’s Scientists from Durin Technologies, Inc., and the University of Medicine and Dentistry of NJ -College of Osteopathic Medicine are suffering from a blood test that uses human proteins microarrays to detect the current presence of specific antibodies in the blood that can be used to diagnose Alzheimer’s disease with unprecedented precision. The test has a diagnostic sensitivity of 96 % and a specificity of 92.5 % and gets the potential to spot Alzheimer’s in its earliest stages, years before symptoms such as for example memory reduction, poor judgment or erratic behavior appear.